Psychother Psychosom August 2025 PMID 40203817

Clinical and Neurophysiological Effects of Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Depression.

Luke J Hearne, Lachlan Webb, Robin Cash, Conor Robinson, Philip E Mosley, Joanna Ng, Simon T Thwaites, Simon Issa, Jessica Miller, Nga Yan Tse, Andrew Zalesky, Bjorn Burgher, Luca Cocchi

Full text PDF Download social card

Mentions

Peak: 28 in Apr 2025

across 4 sources since Apr 2025

Extended reach

78,621

potential audience

Total likes

Video views

576

Mentions per month

Apr 2025 – Jun 2025

Where it's discussed

X / Twitter28 posts
News3 articles
Blogs3 articles
YouTube2 videos

AI synopsis

What people are saying

Discussions around the article reveal enthusiasm for the shift towards personalized neurostimulation treatments, with posts emphasizing the promising clinical outcomes, such as the high remission rates in treated patients. Words like 'excited' and phrases like 'moving from research to real-world clinical use' reflect both interest and positive perception of the potential impact. The tone indicates a mix of hope and curiosity about future developments in mental health therapies.

AgreementModerate agreement

Most discussions express support or optimism about the potential of fMRI-guided rTMS, highlighting excitement for neuro-personalization in mental health treatments.

InterestHigh interest

Posts demonstrate high curiosity, referencing specific results like the 74% response rate and remission percentages, showing engagement with the clinical implications.

EngagementHigh engagement

Several comments delve into the significance of the research, with phrases like 'dawn of neuro-personalization' and 'moving from research to real-world use,' indicating deep interest and reflection.

ImpactModerate impact

While some posts focus on the promising results, there is a sense of cautious optimism rather than this being seen as a definitive breakthrough, suggesting perceived but not fully confirmed impact.

Abstract in brief

rTMS targeting the left DLPFC shows promise in treating refractory major depressive disorder (MDD) by personalizing treatment based on fMRI data, leading to improved outcomes.
In a study of 61 participants aged 19 to 84, significant reductions in depression and anxiety scores were observed, with higher response rates in patients qualifying for randomized trials compared to those with bipolar or neurological disorders.
The results highlight the potential benefits of fMRI-guided rTMS treatment, particularly for patients without additional mental health complications, suggesting a valuable approach for future therapeutic interventions.

Read the full abstract

All mentions

Personalized Brain Stimulation Enhances Treatment for Resistant Depression

Researchers in QIMR Berghofer's Clinical Brain Networks Laboratory developed a personalized transcranial magnetic stimulation guided by brain imaging to treat treatment-resistant depression. This noninvasive method…

QIMR Berghofer · Jun 10, 2025 398 views

Personalized TMS Using Brain Imaging Offers New Hope for Depression Treatment

Medical researchers at QIMR Berghofer have demonstrated the effectiveness of personalized transcranial magnetic stimulation therapy, using brain imaging to tailor treatment, leading to significant symptom reduction in…

QIMR Berghofer · Jun 9, 2025 179 views

Lil Diablo Sauce: Classic Edition

@Nick_Barnes · X

RT @geeknik: Mental health treatment is finally evolving beyond trial-and-error pills. This is the dawn of neuro-personalization. https://t…

Apr 27, 2025 · 1 share · 2,181 followers View post →

✨_geeknik_//✨

@geeknik · X

Mental health treatment is finally evolving beyond trial-and-error pills. This is the dawn of neuro-personalization. https://t.co/PWnFwjF9KS

Apr 27, 2025 · 1 share · 20,808 followers View post →

Charles Laidi

@charles_laidi · X